0001567619-21-022460.txt : 20211222
0001567619-21-022460.hdr.sgml : 20211222
20211222190511
ACCESSION NUMBER: 0001567619-21-022460
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211220
FILED AS OF DATE: 20211222
DATE AS OF CHANGE: 20211222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Treace John T.
CENTRAL INDEX KEY: 0001856380
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40355
FILM NUMBER: 211514406
MAIL ADDRESS:
STREET 1: C/O TREACE MEDICAL CONCEPTS, INC.
STREET 2: 203 FORT WADE ROAD, SUITE 150
CITY: PONTE VEDRA
STATE: FL
ZIP: 32081
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC.
CENTRAL INDEX KEY: 0001630627
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 471052611
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 203 FORT WADE ROAD
STREET 2: SUITE 150
CITY: PONTE VEDRA
STATE: FL
ZIP: 32081
BUSINESS PHONE: (904) 373-5940
MAIL ADDRESS:
STREET 1: 203 FORT WADE ROAD
STREET 2: SUITE 150
CITY: PONTE VEDRA
STATE: FL
ZIP: 32081
4
1
doc1.xml
FORM 4
X0306
4
2021-12-20
0
0001630627
TREACE MEDICAL CONCEPTS, INC.
TMCI
0001856380
Treace John T.
C/O TREACE MEDICAL CONCEPTS, INC.
203 FORT WADE ROAD, SUITE 150
PONTE VEDRA
FL
32081
1
1
1
0
Chief Executive Officer
Common Stock
2021-12-20
4
S
0
22311
15.7372
D
5565269
D
Common Stock
2021-12-20
4
S
0
600
16.3067
D
5564669
D
Common Stock
2021-12-21
4
S
0
34047
16.0851
D
5530622
D
Common Stock
2021-12-21
4
S
0
3537
16.3681
D
5527085
D
Common Stock
1605000
I
By Wife
Common Stock
1471250
I
By Wife as cotrustee of the JTT Irrevocable Trust dated September 30, 2020
Common Stock
1839063
I
As Trustee of the Tracy W. Treace Irrevocable Trust dated September 25, 2020
Common Stock
408816
I
As Co-Trustee of the John R. Treace Irrevocable Trust dated July 29, 2021
Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.205 to $15.935 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.24 to $16.32 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.32 to $16.31 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.32 to $16.45 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee.
/s/ Lisa Taylor as Attorney-in-fact for John T. Treace
2021-12-22